| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13176* | 2021 |
| American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer L Harris, H Fritsche, R Mennel, L Norton, P Ravdin, S Taube, ... Journal of clinical oncology 25 (33), 5287-5312, 2007 | 3311 | 2007 |
| A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer RC Bast Jr, TL Klug, ES John, E Jenison, JM Niloff, H Lazarus, ... New England journal of medicine 309 (15), 883-887, 1983 | 2859 | 1983 |
| Reactivity of a monoclonal antibody with human ovarian carcinoma. RC Bast, M Feeney, H Lazarus, LM Nadler, RB Colvin, RC Knapp The Journal of clinical investigation 68 (5), 1331-1337, 1981 | 2383 | 1981 |
| ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer GY Locker, S Hamilton, J Harris, JM Jessup, N Kemeny, JS Macdonald, ... Journal of clinical oncology 24 (33), 5313-5327, 2006 | 1967 | 2006 |
| The biology of ovarian cancer: new opportunities for translation RC Bast Jr, B Hennessy, GB Mills Nature Reviews Cancer 9 (6), 415-428, 2009 | 1663 | 2009 |
| Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011 | 1489 | 2011 |
| The CA 125 tumour-associated antigen: a review of the literature I Jacobs, RC Bast Jr Human reproduction 4 (1), 1-12, 1989 | 1379 | 1989 |
| Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Z Zhang, RC Bast Jr, Y Yu, J Li, LJ Sokoll, AJ Rai, JM Rosenzweig, ... Cancer research 64 (16), 5882-5890, 2004 | 1313 | 2004 |
| A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass RG Moore, DS McMeekin, AK Brown, P DiSilvestro, MC Miller, WJ Allard, ... Gynecologic oncology 112 (1), 40-46, 2009 | 1277 | 2009 |
| 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology RC Bast Jr, P Ravdin, DF Hayes, S Bates, H Fritsche Jr, JM Jessup, ... Journal of clinical oncology 19 (6), 1865-1878, 2001 | 1157 | 2001 |
| The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass RG Moore, AK Brown, MC Miller, S Skates, WJ Allard, T Verch, ... Gynecologic oncology 108 (2), 402-408, 2008 | 1139 | 2008 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1136 | 2015 |
| Overexpression of HER-2/neu Is Associated with Poor Survival in Advanced Epithelial Ovarian Cancer A Berchuck, A Kamel, R Whitaker, B Kerns, G Olt, R Kinney, JT Soper, ... Cancer research 50 (13), 4087-4091, 1990 | 1077 | 1990 |
| Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A X Fang, SX Yu, Y Lu, RC Bast Jr, JR Woodgett, GB Mills Proceedings of the National Academy of Sciences 97 (22), 11960-11965, 2000 | 1039 | 2000 |
| Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology clinical practice … LN Harris, N Ismaila, LM McShane, DF Hayes Journal of oncology practice 12 (4), 384-389, 2016 | 990 | 2016 |
| Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers DF Hayes, RC Bast, CE Desch, H Fritsche Jr, NE Kemeny, JM Jessup, ... JNCI: Journal of the National Cancer Institute 88 (20), 1456-1466, 1996 | 985 | 1996 |
| Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation SJ Brandt, WP Peters, SK Atwater, J Kurtzberg, MJ Borowitz, RB Jones, ... New England Journal of Medicine 318 (14), 869-876, 1988 | 918 | 1988 |
| Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125 SE Kabawat, RC Bast Jr, AK Bhan, WR Welch, RC Knapp, RB Colvin International Journal of Gynecological Pathology 2 (3), 275-285, 1983 | 895 | 1983 |
| National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brunner, DW Chan, ... Clinical chemistry 54 (12), e11-e79, 2008 | 839* | 2008 |
